Market cap:
$65.57B+$1.30B(+2.03%)Summary
- As of today (April 25, 2025), REGN market capitalization is $65.57 billion, with a rise of +$1.30 billion (+2.03%) during the most recent trading session on April 24, 2025.
- Over the past year, REGN market cap has dropped by -$32.47 billion (-33.12%).
- REGN market cap is now -50.40% below its all-time high of $132.20 billion.
Performance
REGN Market cap Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Related metrics
Market cap Formula
Market Cap = Price ✕ Shares Outstanding
REGN Market cap Trends
| PeriodPeriod | Market capMarket cap | PricePrice | Shares outstandingShares outstanding | Enterprise valueEnterprise value |
|---|---|---|---|---|
| todaytoday | +2.0% | +2.0% | -0.3% | +2.0% |
| 1 m1 month | -5.4% | -5.4% | - | -5.4% |
| 3 m3 months | -11.1% | -11.3% | - | -11.1% |
| 6 m6 months | -35.9% | -35.7% | - | -34.4% |
| ytdytd | -14.7% | -15.8% | - | -14.6% |
| 1 y1 year | -33.1% | -32.7% | -0.8% | -33.0% |
| 5 y5 years | +2.9% | +5.9% | -2.8% | +5.7% |
REGN Market cap Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | $72.26B | -9.3% | $59.73B | +9.8% |
| 3 m | 3-month | $81.93B | -20.0% | $59.73B | +9.8% |
| 6 m | 6-month | $105B | -37.8% | $59.73B | +9.8% |
| 1 y | 1-year | $132B | -50.4% | $59.73B | +9.8% |
| 3 y | 3-year | $132B | -50.4% | $59.73B | +9.8% |
| 5 y | 5-year | $132B | -50.4% | $47.86B | +37.0% |
| alltime | all time | $132B | -50.4% | $56.59M | >+9999.0% |
Regeneron Pharmaceuticals Market cap History
| Date | Value |
|---|---|
| 2025 | $65.57B(-14.7%) |
| 2024 | $76.84B(-19.8%) |
| 2023 | $95.76B(+21.0%) |
| 2022 | $79.13B(+15.3%) |
| 2021 | $68.63B(+32.8%) |
| 2020 | $51.67B(+24.8%) |
| 2019 | $41.41B(+1.7%) |
| 2018 | $40.71B(+0.6%) |
| 2017 | $40.46B(+4.0%) |
| 2016 | $38.91B(-31.5%) |
| 2015 | $56.81B(+35.2%) |
| 2014 | $42.02B(+53.2%) |
| 2013 | $27.44B(+64.9%) |
| 2012 | $16.64B(+223.6%) |
| 2011 | $5.14B(+75.2%) |
| 2010 | $2.94B(+49.7%) |
| 2009 | $1.96B(+34.1%) |
| Date | Value |
|---|---|
| 2008 | $1.46B(-23.2%) |
| 2007 | $1.90B(+45.1%) |
| 2006 | $1.31B(+46.3%) |
| 2005 | $897.38M(+74.4%) |
| 2004 | $514.47M(-37.1%) |
| 2003 | $817.33M(-0.8%) |
| 2002 | $823.76M(-33.5%) |
| 2001 | $1.24B(-4.6%) |
| 2000 | $1.30B(+224.0%) |
| 1999 | $400.64M(+75.1%) |
| 1998 | $228.76M(-13.6%) |
| 1997 | $264.77M(-36.0%) |
| 1996 | $414.03M(+48.7%) |
| 1995 | $278.40M(+392.0%) |
| 1994 | $56.59M(-80.6%) |
| 1993 | $292.24M(+58.6%) |
| 1992 | $184.24M(-33.8%) |
| 1991 | $278.45M |
FAQ
- What is Regeneron Pharmaceuticals market capitalization?
- What is the all time high market cap for Regeneron Pharmaceuticals?
- What is REGN market capitalization year-to-date change?
- What is Regeneron Pharmaceuticals market cap year-on-year change?
What is Regeneron Pharmaceuticals market capitalization?
The current market cap of REGN is $65.57B
What is the all time high market cap for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high market capitalization is $132.20B
What is REGN market capitalization year-to-date change?
Regeneron Pharmaceuticals market capitalization has changed by -$11.27B (-14.67%) since the beginning of the year
What is Regeneron Pharmaceuticals market cap year-on-year change?
Over the past year, REGN market capitalization has changed by -$32.47B (-33.12%)